Можливості оптимізації лікування дифузного токсичного зоба шляхом корекції функціональних порушень печінки

І. І. Свистун

doi:10.24026/1818-1384.3(36).2011.87099

Автор(и)

І. І. Свистун Тернопільський державний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

DOI:

https://doi.org/10.24026/1818-1384.3(36).2011.87099

Ключові слова:

thyroid, diffuse toxic goiter, liver, lipoic acid

Анотація

The effect of α-lipoic acid on functional liver changes of patients with a diffuse toxic goiter during the month was studied. Positive influence on the indices of aminotranferases, bilirubine, alkaline phosphatase, total protein and also reduction of oxidative stress and decreased of endogenous intoxication level were shown that allows to recommend lipoic acid as as an adjuvant in the treatment of patients with diffuse toxic goiter.

Біографія автора

І. І. Свистун, Тернопільський державний медичний університет ім. І.Я. Горбачевського, Тернопіль

I. Svystun

Посилання

Паньків В. І. Практична тиреоїдологія (монографія). Донецьк: Заславський О. Ю., 2011. – 224 с.

Beckett G.J., Kellett H.A., Gow S.M., Hussey A.J., Hayes J.D., Toft A.D. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage // Br. Med. J. (Clin Res Ed). – 1985. – Vol. 291 (6493). – P. 427-431. https://doi.org/10.1136/bmj.291.6493.427

Bianchi G.P., Zoli M., Marchesini G., Volta U., Vecchi F., Iervese T., Bonazzi C., Pisi E. Thyroid gland size and function in patients with cirrhosis of the liver // Liver. – 1991. – Vol. 11. – P. 71-77. https://doi.org/10.1111/j.1600-0676.1991.tb00495.x

Biscoveanu M., Hasinski S. Abnormal results of liver function tests in patients with Graves' disease // Endocr. Pract. – 2000. – Vol. 6. – P. 367-369. https://doi.org/10.4158/ep.6.5.367

Crowe J.P., Christensen E., Butler J., Wheeler P., Doniach D., Keenan J., Williams R. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome // Gastroenterology. – 1980. – Vol.78. – P. 1437-1441.

Fuad S., Ashkar M., Miller R. et al. Liver disease in hyperthyroidism // Southern medical journal. – 1971. – Vol. 64, № 4. https://doi.org/10.1097/00007611-197104000-00016

Gurlek A., Cobankara V., Bayraktar M. Liver tests in hyperthyroidism: effect of antithyroid therapy / / J. Clin. Gastroenterol. 1997. – Vol. 24. – P. 180-183. https://doi.org/10.1097/00004836-199704000-00013

Kim H.J., Kim B.H., Han Y.S., Yang I., Kim K.J., Dong S.H., Chang Y.W., Lee J.I., Chang R. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study // Am. J. Gastroenterol. – 2001. – Vol. 96. – P. 165-169. https://doi.org/10.1111/j.1572-0241.2001.03469.x

Krawitt E.L. Autoimmune hepatitis // N. Engl. J. Med. – 1996. – Vol. 334. – P. 897-903. https://doi.org/10.1056/nejm199604043341406

L'age M., Meinhold H., Wenzel K.W., Schleusener H. Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases // J. Endocrinol. Invest. – 1980. – Vol. 3. – P. 379-383. https://doi.org/10.1007/bf03349374

Larsen P.R., Berry M.J. Nutritional and hormonal regulation of thyroid hormone deiodinases. Ann. Rev. Nutr. – 1995. – Vol. 15. – P. 323-352. https://doi.org/10.1146/annurev.nu.15.070195.001543

Leonard J.L., Kohrle J. Intracellular pathways of iodothyronine metabolism. In: Braverman L.E., Utiger R.D. (eds). The Thyroid. – Philadelphia: Lippincott-Raven, 1996. – P. 125-161.

Levy M. Propylthiouracil hepatotoxicity: a review and case presentation // Clin. Pediatr. (Phila) – 1993. – Vol. 32. – P. 25-29. https://doi.org/10.1177/000992289303200105

Malik R., Hodgson H. The relationship between the thyroid gland and the liver // QJM. – 2002. – Vol. 95. – P. 559-569. https://doi.org/10.1093/qjmed/95.9.559

Mendel C.M., Cavalieri R.R., Weisiger R.A. Uptake of thyroxine by the perfused rat liver: implications for the free hormone hypothesis // Am. J. Physiol. – 1988. – Vol. 255. – P. E110-119.

Sakurabayashi S., Sezai S., Yamamoto Y., Yoshino K., Hirano M., Iwase T., Oka H., Okano K. Reduced thyroidal uptake of inorganic iodine in liver cirrhosis // J. Med. – 1996. – Vol. 27 (3-4). – P. 193-204.

Vasillopoulou-Sellin R., Sellin J.H. In: Werner and Ingbar's. The Thyroid: A Fundamental and Clinical Text. Braverman L.E., Utiger R.D., (eds). – Philadelphia, PA: Lippincott-Raven, 1996. – Vol. 47. – P. 632-636.

Visser T.J. Pathways of thyroid hormone metabolism // Acta Med. Austr. – 1996. – Vol. 23. – P. 10-16.

Williams K.V., Nayak S., Becker D., Reyes J., Burmeister L.A. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? // J. Clin. Endocrinol. Metab. – 1997. – Vol. 82. – P. 1727-1733. https://doi.org/10.1210/jcem.82.6.4011